GlassScriptPhysician profile
Alfred T Ogden
NPI 1174795116
$39,239.70
in general payments reported to CMS, 2019-2025
17 companies · $7,721 in 2025
The $7,721 reported for 2025 was more than what 83% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $916 · 2020: $5,022 · 2021: $14K · 2022: $7,095 · 2023: $2,884 · 2024: $1,154 · 2025: $7,721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,325 · Travel and Lodging: $1,894 · Food and Beverage: $1,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,325.00 |
| Travel and Lodging | $1,894.28 |
| Food and Beverage | $1,539.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viseon, INC. | $23,930.40 | 2020-2024 | Maxview System - Lateral Set |
| Zavation Medical Products, LLC | $7,500.10 | 2025 | |
| Nuvasive, INC. | $5,642.68 | 2021-2023 | Acp |
| Medical Device Business Services, INC. | $560.26 | 2019 | |
| Medtronic, INC. | $433.74 | 2022-2024 | Aquamantys(Tm), Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $321.52 | 2019-2021 | |
| Alphatec Spine, INC | $155.32 | 2023 | |
| Providence Medical Technology, INC. | $138.55 | 2024-2025 | |
| Nevro Corp. | $106.87 | 2023 | Senza |
| Globus Medical, INC. | $104.45 | 2025 | Senza |
| Stryker Corporation | $82.54 | 2022 | |
| Abbott Laboratories | $77.53 | 2019-2021 | |
| Gt Medical Technologies, INC | $61.76 | 2025 | Gammatile |
| Zimvie INC. | $48.16 | 2024 | |
| Orthofix Medical, INC. | $32.50 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $28.32 | 2019 | |
| Theragen, INC. | $15.00 | 2023 | Actastim-S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,711,451.36 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfred Ogden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.